Advanced Biomed Inc. (ADVB): Total Liabilities
$1.47M
As of 2026-06-30
$1.61M
As of 2026-09-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.47M | -92.4% | 2026-10-13, Balance as of period end |
| 2025-06-30 | $19.38M | +593.0% | 2026-10-13, Balance as of period end |
| 2024-06-30 | $2.80M | n/a | 2025-10-08, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | 2026-06-30 | $1.47M | -92.4% |
| YD Bio Ltd (YDES) | 2025-12-31 | $16.64M | n/m |
| Aclarion, Inc. (ACON) | 2025-12-31 | $837.3K | -27.4% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $637.9K | -69.8% |
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | $43.58M | +17.8% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
| Freenome, Inc. (FRNM) | 2025-12-31 | $5.70M | +55.8% |
Compare ADVB, YDES, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗